Atsuko Watanabe
Comptroller/Controller/Auditor bei HanaVax, Inc.
Profil
Atsuko Watanabe is currently working as an Auditor at HanaVax, Inc. since 2018.
Previously, she worked as a Manager-Business Development at OncoTherapy Science, Inc. in 2019.
Aktive Positionen von Atsuko Watanabe
| Unternehmen | Position | Beginn |
|---|---|---|
HanaVax, Inc.
 HanaVax, Inc. BiotechnologyHealth Technology HanaVax, Inc. develops nasal vaccine against infectious diseases. It develops pneumococcal nasal vaccine to prevent pneumonia, sepsis and otitis media. The company was founded by Hosei Ou on December 27, 2017 and is headquartered in Tokyo, Japan. | Comptroller/Controller/Auditor | 01.11.2018 |
Ehemalige bekannte Positionen von Atsuko Watanabe
| Unternehmen | Position | Ende |
|---|---|---|
| ONCOTHERAPY SCIENCE, INC. | Direktor/Vorstandsmitglied | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| ONCOTHERAPY SCIENCE, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
HanaVax, Inc.
HanaVax, Inc. BiotechnologyHealth Technology HanaVax, Inc. develops nasal vaccine against infectious diseases. It develops pneumococcal nasal vaccine to prevent pneumonia, sepsis and otitis media. The company was founded by Hosei Ou on December 27, 2017 and is headquartered in Tokyo, Japan. | Health Technology |
